The Novartis Biome HealthHub 21 Challenge

April 20, 2021
in collaboration with KQ Labs and LifeArc

Digitising patient pathways and advancing remote care in a COVID era

Why a HealthHub 21 Challenge?

The NHS and its partners are facing unprecedented challenges as a result of the COVID-19 pandemic and need to further accelerate their digital transformation at a pace never seen before. Following the success of our 2020 HealthHub, we are now launching the Novartis Biome HealthHub 21 Challenge. 

This year Novartis is excited to announce a new collaboration with KQ Labs, the data-driven health accelerator of the Francis Crick Institute, and LifeArc, the charity helping turn promising science into benefits for patients. 

Together Novartis, KQ Labs, and LifeArc have a shared commitment to supporting the data-driven health ecosystem in the UK, and are launching the HealthHub 21 Challenge to foster collaboration in digital health and support the NHS to transform patient pathways.

Why should you apply?

The selected companies will have the unique opportunity to benefit from:


Resources, expertise and opportunities with Novartis

  • Access to coaching & mentoring with Novartis experts from functions such as marketing, commercial, market access strategy, health economics and medical affairs
  • Proof of concept testing opportunities, with our partners in the health ecosystem
  • Access to the Novartis UK Biome’s enablement network from across a variety of industries

Mentoring opportunities from the KQ Labs data-driven health accelerator team and expert network

  • Mentoring sessions with the KQ Labs team
  • Access to the KQ Labs’ data-driven health network

Investment 

  • Funding from LifeArc in the form of a Convertible Loan for £50,000

 

Apply Now

What are we looking for?

We are searching for companies who can help accelerate and scale digital health solutions that will support the NHS to digitise the patient journey and advance the remote care agenda. In particular, we are looking for:


Companies with innovative solutions that apply to one of the following therapeutic areas:

  • Cardiovascular
  • Ophthalmology
  • Dermatology
  • Rheumatology
  • Neuroscience
  • Gene Therapy
  • Oncology (Solid tumours: Breast, Melanoma, Lung/Haematology: Immune Thrombocytopenic Purpura (ITP), Chronic Myeloid Leukemia (CLM), Myelofibrosis (MF), targeted radioligand therapy)


Companies who have:

  • A working product for their Potential Solution at the time of application, at least in beta stage
  • Two or more co-founders or staff
  • A team based in the UK 
  • The company's legal entity must be UK based
  • Any stage from pre-seed to Series B

 

Key dates for the HealthHub 21 Challenge:


Applications open: 20 April 2021

  • Submit your application details and slide deck below

Application deadline: 25 May 2021

  • Submit your online application by 25 May at 12 noon 

Pitch day: 23 June 2021

  • Selected finalists will have the opportunity to pitch their solutions to a panel of experts from Novartis, KQ Labs, LifeArc and the NHS (non-public)

Final winner announcement: 7 July 2021

  • The selected winner(s) will be announced at a public webinar on 7 July at 2pm


How to apply:

Please email us at [email protected] ensuring you include the following details: 
* Primary contact full name: 
* Email address: 
* Role in company:
* Company name:
* Website:
* Size of team:
* Registered address:
* One sentence summary statement describing your company and vision:
* Why are you applying for this Challenge?


Along with your email, please submit a slide deck of no more than 15 slides covering:

  • Problem you are trying to solve
  • Your solution
    • Is the solution Disease or Therapy Area agnostic or how does it relate to one of the therapeutic areas in this Challenge?
    • How is the solution scalable?
  • Market need and opportunity
  • Competitors, including other approaches to solving this problem
  • Business model (an outline of your route to commercialization)
  • Traction (what evidence do you have so far for interest in, or potential uptake of, your product?
    • What funds, if any, have you raised so far?
  • Intellectual Property (if applicable) or your competitive advantage
  • The team
  • Roadmap and key milestones

 

Your personal data will be processed in accordance with our General Privacy Notice for Suppliers. If sharing slides, you have the right to disclose the information and should not include anything in the materials that you submit that infringes on a third party’s intellectual property rights.

 

For any questions please contact us at [email protected]

 

Please note: The Novartis Biome HealthHub 21 is a Challenge which is distinct and complementary to the KQ Labs core data-driven health Accelerator Programme.

This will run later in the year, with applications opening in May 2021.

UK | April 2021 | 119825